Verastem | VSTM - Sales Revenues

Stock Price
6.09
Daily Change
-0.44 -6.67%
Monthly
12.89%
Yearly
-13.57%
Q2 Forecast
6.44

Verastem reported $17.54M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
AbbVie USD 16.62B 840M Dec/2025
Alaunos Therapeutics USD 2K 2K Mar/2025
AstraZeneca USD 15.5B 313M Dec/2025
Curis USD 1.14M 1.41M Dec/2025
Cytokinetics USD 17.76M 15.83M Dec/2025
Gilead Sciences USD 7.93B 130M Dec/2025
Incyte USD 1.51B 140M Dec/2025
Laboratory Of America USD 3.52B 40M Dec/2025
Novartis USD 13.86B 50M Dec/2025
Pfizer USD 17.58B 880M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
TG Therapeutics USD 192.57M 30.87M Dec/2025
Verastem USD 17.54M 7.53M Dec/2025